SMIM10L2B and glioblastoma: The Kaplan–Meier survival analysis showed that RP11-399O19.9 and LINC00087 are able to separate patients into higher and lower risk groups by median PI, with the value of p of Log-rank of 0.043875 and 0.024661 for GBM.